ID

26302

Description

Study of CR011-vcMMAE to Treat Locally Advanced or Metastatic Breast Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00704158

Link

https://clinicaltrials.gov/show/NCT00704158

Keywords

Versions (1)
  1. 10/16/17 10/16/17 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

October 16, 2017

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Breast Cancer NCT00704158

English

Eligibility Breast Cancer NCT00704158

1 forms  
Criteria
Description

Criteria

females with confirmed breast cancer
Description

Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1]
C0678222
age ≥ 18 years
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
eastern cooperative oncology group (ecog) performance status 0 to 2
Description

ECOG performance status

Data type

boolean

Alias
UMLS CUI [1]
C1520224
locally advanced or metastatic disease who have received at least two prior chemotherapeutic regimens for breast cancer, as follows:
Description

Advanced disease Locally | Neoplasm Metastasis | Chemotherapy Regimen Quantity Breast Carcinoma

Data type

boolean

Alias
UMLS CUI [1,1]
C0679246
UMLS CUI [1,2]
C1517927
UMLS CUI [2]
C0027627
UMLS CUI [3,1]
C0392920
UMLS CUI [3,2]
C1265611
UMLS CUI [3,3]
C0678222
at least one regimen must have been for locally advanced or metastatic disease
Description

Chemotherapy Regimen Quantity Advanced disease Locally | Chemotherapy Regimen Quantity Neoplasm Metastasis

Data type

boolean

Alias
UMLS CUI [1,1]
C0392920
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0679246
UMLS CUI [1,4]
C1517927
UMLS CUI [2,1]
C0392920
UMLS CUI [2,2]
C1265611
UMLS CUI [2,3]
C0027627
subject must have received an anthracycline, a taxane, and capecitabine in any combination unless the subject was intolerant to or not a candidate for any of these agents
Description

Anthracycline | taxane | capecitabine | Combined Modality Therapy | Exception Intolerance to substance | Exception Patient Inappropriate Medication

Data type

boolean

Alias
UMLS CUI [1]
C0282564
UMLS CUI [2]
C0215136
UMLS CUI [3]
C0671970
UMLS CUI [4]
C0009429
UMLS CUI [5,1]
C1705847
UMLS CUI [5,2]
C1744706
UMLS CUI [6,1]
C1705847
UMLS CUI [6,2]
C0030705
UMLS CUI [6,3]
C1548788
UMLS CUI [6,4]
C0013227
hormonal therapy, biologic therapy (such as trastuzumab or bevacizumab), or immunotherapy do not count as one of the 2 regimens
Description

Hormone Therapy Excluded | Biological treatment Excluded | trastuzumab | bevacizumab | Immunotherapy Excluded

Data type

boolean

Alias
UMLS CUI [1,1]
C0279025
UMLS CUI [1,2]
C2828389
UMLS CUI [2,1]
C1531518
UMLS CUI [2,2]
C2828389
UMLS CUI [3]
C0728747
UMLS CUI [4]
C0796392
UMLS CUI [5,1]
C0021083
UMLS CUI [5,2]
C2828389
subjects with her2/neu overexpressing tumors must have been treated with trastuzumab except in situations where the subject was intolerant to or not a candidate for trastuzumab
Description

Neoplasm HER2/neu Overexpression | trastuzumab | Exception Intolerance to trastuzumab | Exception Patient Inappropriate trastuzumab

Data type

boolean

Alias
UMLS CUI [1,1]
C0027651
UMLS CUI [1,2]
C1702024
UMLS CUI [1,3]
C1514559
UMLS CUI [2]
C0728747
UMLS CUI [3,1]
C1705847
UMLS CUI [3,2]
C1744706
UMLS CUI [3,3]
C0728747
UMLS CUI [4,1]
C1705847
UMLS CUI [4,2]
C0030705
UMLS CUI [4,3]
C1548788
UMLS CUI [4,4]
C0728747
documented progressive disease within 6 months of the last regimen
Description

Progressive Disease

Data type

boolean

Alias
UMLS CUI [1]
C1335499
adequate bone marrow, renal and liver function
Description

Bone Marrow function | Renal function | Liver function

Data type

boolean

Alias
UMLS CUI [1,1]
C0005953
UMLS CUI [1,2]
C0031843
UMLS CUI [2]
C0232804
UMLS CUI [3]
C0232741
signed informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
main exclusion criteria:
Description

Exclusion Criteria Main

Data type

boolean

Alias
UMLS CUI [1,1]
C0680251
UMLS CUI [1,2]
C1542147
chemotherapy, radiation, hormonal therapy, or bevacizumab within two weeks, or trastuzumab or investigational therapy within three weeks before treatment start
Description

Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | bevacizumab | trastuzumab | Therapy, Investigational

Data type

boolean

Alias
UMLS CUI [1]
C0392920
UMLS CUI [2]
C1522449
UMLS CUI [3]
C0279025
UMLS CUI [4]
C0796392
UMLS CUI [5]
C0728747
UMLS CUI [6]
C0949266
neuropathy > nci-ctcae grade 1
Description

Neuropathy CTCAE Grades

Data type

boolean

Alias
UMLS CUI [1,1]
C0442874
UMLS CUI [1,2]
C1516728
active brain metastases.
Description

Metastatic malignant neoplasm to brain

Data type

boolean

Alias
UMLS CUI [1]
C0220650
new york heart association class iii or iv heart disease
Description

Heart Disease New York Heart Association Classification

Data type

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C1275491
unstable angina
Description

Angina, Unstable

Data type

boolean

Alias
UMLS CUI [1]
C0002965
uncontrolled arrhythmia
Description

Cardiac Arrhythmia Uncontrolled

Data type

boolean

Alias
UMLS CUI [1,1]
C0003811
UMLS CUI [1,2]
C0205318
a marked baseline prolongation of qt/qtc interval
Description

Prolonged QT interval | Prolonged QTc interval

Data type

boolean

Alias
UMLS CUI [1]
C0151878
UMLS CUI [2]
C1560305
pregnant or breast-feeding women, and women of childbearing age and potential who are not willing to use effective contraception
Description

Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Unwilling

Data type

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
UMLS CUI [3,1]
C3831118
UMLS CUI [3,2]
C0700589
UMLS CUI [3,3]
C0558080
Back to the top of the page

Similar models

Eligibility Breast Cancer NCT00704158

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
Breast Carcinoma
Item
females with confirmed breast cancer
boolean
C0678222 (UMLS CUI [1])
Age
Item
age ≥ 18 years
boolean
C0001779 (UMLS CUI [1])
ECOG performance status
Item
eastern cooperative oncology group (ecog) performance status 0 to 2
boolean
C1520224 (UMLS CUI [1])
Advanced disease Locally | Neoplasm Metastasis | Chemotherapy Regimen Quantity Breast Carcinoma
Item
locally advanced or metastatic disease who have received at least two prior chemotherapeutic regimens for breast cancer, as follows:
boolean
C0679246 (UMLS CUI [1,1])
C1517927 (UMLS CUI [1,2])
C0027627 (UMLS CUI [2])
C0392920 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0678222 (UMLS CUI [3,3])
Chemotherapy Regimen Quantity Advanced disease Locally | Chemotherapy Regimen Quantity Neoplasm Metastasis
Item
at least one regimen must have been for locally advanced or metastatic disease
boolean
C0392920 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0679246 (UMLS CUI [1,3])
C1517927 (UMLS CUI [1,4])
C0392920 (UMLS CUI [2,1])
C1265611 (UMLS CUI [2,2])
C0027627 (UMLS CUI [2,3])
Anthracycline | taxane | capecitabine | Combined Modality Therapy | Exception Intolerance to substance | Exception Patient Inappropriate Medication
Item
subject must have received an anthracycline, a taxane, and capecitabine in any combination unless the subject was intolerant to or not a candidate for any of these agents
boolean
C0282564 (UMLS CUI [1])
C0215136 (UMLS CUI [2])
C0671970 (UMLS CUI [3])
C0009429 (UMLS CUI [4])
C1705847 (UMLS CUI [5,1])
C1744706 (UMLS CUI [5,2])
C1705847 (UMLS CUI [6,1])
C0030705 (UMLS CUI [6,2])
C1548788 (UMLS CUI [6,3])
C0013227 (UMLS CUI [6,4])
Hormone Therapy Excluded | Biological treatment Excluded | trastuzumab | bevacizumab | Immunotherapy Excluded
Item
hormonal therapy, biologic therapy (such as trastuzumab or bevacizumab), or immunotherapy do not count as one of the 2 regimens
boolean
C0279025 (UMLS CUI [1,1])
C2828389 (UMLS CUI [1,2])
C1531518 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0728747 (UMLS CUI [3])
C0796392 (UMLS CUI [4])
C0021083 (UMLS CUI [5,1])
C2828389 (UMLS CUI [5,2])
Neoplasm HER2/neu Overexpression | trastuzumab | Exception Intolerance to trastuzumab | Exception Patient Inappropriate trastuzumab
Item
subjects with her2/neu overexpressing tumors must have been treated with trastuzumab except in situations where the subject was intolerant to or not a candidate for trastuzumab
boolean
C0027651 (UMLS CUI [1,1])
C1702024 (UMLS CUI [1,2])
C1514559 (UMLS CUI [1,3])
C0728747 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C1744706 (UMLS CUI [3,2])
C0728747 (UMLS CUI [3,3])
C1705847 (UMLS CUI [4,1])
C0030705 (UMLS CUI [4,2])
C1548788 (UMLS CUI [4,3])
C0728747 (UMLS CUI [4,4])
Progressive Disease
Item
documented progressive disease within 6 months of the last regimen
boolean
C1335499 (UMLS CUI [1])
Bone Marrow function | Renal function | Liver function
Item
adequate bone marrow, renal and liver function
boolean
C0005953 (UMLS CUI [1,1])
C0031843 (UMLS CUI [1,2])
C0232804 (UMLS CUI [2])
C0232741 (UMLS CUI [3])
Informed Consent
Item
signed informed consent
boolean
C0021430 (UMLS CUI [1])
Exclusion Criteria Main
Item
main exclusion criteria:
boolean
C0680251 (UMLS CUI [1,1])
C1542147 (UMLS CUI [1,2])
Chemotherapy | Therapeutic radiology procedure | Hormone Therapy | bevacizumab | trastuzumab | Therapy, Investigational
Item
chemotherapy, radiation, hormonal therapy, or bevacizumab within two weeks, or trastuzumab or investigational therapy within three weeks before treatment start
boolean
C0392920 (UMLS CUI [1])
C1522449 (UMLS CUI [2])
C0279025 (UMLS CUI [3])
C0796392 (UMLS CUI [4])
C0728747 (UMLS CUI [5])
C0949266 (UMLS CUI [6])
Neuropathy CTCAE Grades
Item
neuropathy > nci-ctcae grade 1
boolean
C0442874 (UMLS CUI [1,1])
C1516728 (UMLS CUI [1,2])
Metastatic malignant neoplasm to brain
Item
active brain metastases.
boolean
C0220650 (UMLS CUI [1])
Heart Disease New York Heart Association Classification
Item
new york heart association class iii or iv heart disease
boolean
C0018799 (UMLS CUI [1,1])
C1275491 (UMLS CUI [1,2])
Angina, Unstable
Item
unstable angina
boolean
C0002965 (UMLS CUI [1])
Cardiac Arrhythmia Uncontrolled
Item
uncontrolled arrhythmia
boolean
C0003811 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
Prolonged QT interval | Prolonged QTc interval
Item
a marked baseline prolongation of qt/qtc interval
boolean
C0151878 (UMLS CUI [1])
C1560305 (UMLS CUI [2])
Pregnancy | Breast Feeding | Childbearing Potential Contraceptive methods Unwilling
Item
pregnant or breast-feeding women, and women of childbearing age and potential who are not willing to use effective contraception
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C3831118 (UMLS CUI [3,1])
C0700589 (UMLS CUI [3,2])
C0558080 (UMLS CUI [3,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial